CompletedNot Applicable

Evaluating the SWW Method Dietary Intervention for HbA1c and Weight Management as a Preventative Intervention in Women

United States85 participantsStarted 2024-04-01

Plain-language summary

This study evaluated the SWW Method®, a 12-week dietary and lifestyle intervention based on the carbohydrate-insulin model, in a healthy cohort of women aged 35-75. The study assessed whether the intervention resulted in significant improvements in blood glucose markers (HbA1c, fasting blood glucose), weight, BMI, and other metabolic markers compared to a no-intervention control group. The SWW Method® protocol includes intermittent fasting, a protein-forward diet, meal sequencing, hydration, magnesium supplementation, and sleep support. This was a non-randomized case-control trial with 45 intervention participants and 40 controls, conducted over 12 weeks.

Who can participate

Age range35 Years – 75 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female * 35-75 years of age * No prior enrollment in the SWW Method® or Sarah Wragge Wellness® program. Exclusion Criteria: * History of non-skin-related cancer diagnosis or treatment within the past five years. * Currently taking weight loss medication, including semaglutide * Currently taking any medication for blood sugar or diabetes management. * Previous enrollment in the SWW Method® or any Sarah Wragge Wellness® program.

What they're measuring

Change in Body Weight

Timeframe: Baseline and 12 weeks

Change in HbA1c Time Frame: Baseline and 12 weeks

Timeframe: Baseline and 12 weeks

Change in BMI

Timeframe: Baseline and 12 weeks

Change in Fasting Blood Glucose

Timeframe: Baseline and 12 weeks

Trial details

NCT IDNCT07463417

SponsorSarah Wragge Wellness

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2025-06-06

View on ClinicalTrials.gov More Metabolic Syndrome trials